Urinary excretion of GH in healthy individuals and patients with acromegaly, hypopituitarism and dwarfism
- PMID: 8447191
- DOI: 10.1530/acta.0.1280024
Urinary excretion of GH in healthy individuals and patients with acromegaly, hypopituitarism and dwarfism
Abstract
Urinary GH excretion reflects average plasma levels. Using a highly sensitive sandwich enzyme immunoassay we determined GH concentrations in the 24 h accumulated urine samples of 54 healthy persons (aged 1.5-90 years), 8 acromegalic patients, 4 acromegalic patients after enucleation of a GH-producing adenoma, 8 patients with partial hypopituitarism and in first morning urine and 12 h accumulated daytime urine of 4 healthy children and 3 children with growth failure. GH secretion is age-dependent, with high rates between ages 1 and 20 (ages 0-20 years: 10.4 ng/g creatinine +/- 6.3 vs age > 20-75 years: 3.1 ng/g creatinine +/- 1.6). An age-dependent increase in urinary GH is found in the pubertal age group (10 ng/24 h +/- 6.8 vs prepubertal group: 4.6 ng/24 h +/- 2.95). GH excretion of patients with acromegaly differs significantly from healthy subjects (72 ng/24 h +/- 49 vs 3.9 ng/24 h +/- 2.3). After a successful operation, acromegalic patients do not differ from the collective norm. Six of 8 patients with partial hypopituitarism show lower GH concentrations in urine than healthy subjects (1.2 ng/l +/- 0.2 vs 2.6 ng/l +/- 1.2), but daily GH output does not differ, since significantly more urine is then excreted. At night, healthy children secrete significantly more GH than during the day (night: 0.16 ng.kg-1 x (12 h)-1 +/- 0.02 vs day: 0.07 ng.kg-1 x (12 h)-1 +/- 0.03), while output is the same for GH-deficient children. Both groups have similar GH daytime output, but GH-deficient children have significantly less nocturnal output.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Urinary growth hormone (GH) measurements are useful for evaluating endogenous GH secretion.J Clin Endocrinol Metab. 1988 Jun;66(6):1119-23. doi: 10.1210/jcem-66-6-1119. J Clin Endocrinol Metab. 1988. PMID: 3286672
-
Urinary growth hormone excretion rates in normal and acromegalic man: a critical appraisal of its potential clinical utility.J Endocrinol Invest. 1989 Jul-Aug;12(7):461-7. doi: 10.1007/BF03350732. J Endocrinol Invest. 1989. PMID: 2677110
-
Clinical usefulness of urinary growth hormone measurements in normal and short children according to different expressions of urinary growth hormone data.Pediatr Res. 1992 Jul;32(1):73-6. doi: 10.1203/00006450-199207000-00014. Pediatr Res. 1992. PMID: 1635848
-
Current methods for the measurement of growth hormone in urine.Clin Endocrinol (Oxf). 1994 Feb;40(2):155-70. doi: 10.1111/j.1365-2265.1994.tb02462.x. Clin Endocrinol (Oxf). 1994. PMID: 8137512 Review.
-
Mortality in Acromegalic Patients: Etiology, Trends, and Risk Factors.Cureus. 2021 Apr 2;13(4):e14265. doi: 10.7759/cureus.14265. Cureus. 2021. PMID: 33959447 Free PMC article. Review.
Cited by
-
Application of Analyte Harvesting Nanoparticle Technology to the Measurement of Urinary HGH in Healthy Individuals.J Sports Med Doping Stud. 2012;2(6):e127. doi: 10.4172/2161-0673.1000e127. J Sports Med Doping Stud. 2012. PMID: 24014257 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous